These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31128515)

  • 21. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
    Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
    Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y
    Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin.
    Sun S; Liang N; Yamamoto H; Kawashima Y; Cui F; Yan P
    Int J Nanomedicine; 2015; 10():3489-98. PubMed ID: 25999713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
    Fatma S; Talegaonkar S; Iqbal Z; Panda AK; Negi LM; Goswami DG; Tariq M
    Drug Deliv; 2016; 23(2):500-11. PubMed ID: 24937381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin.
    Lopes M; Shrestha N; Correia A; Shahbazi MA; Sarmento B; Hirvonen J; Veiga F; Seiça R; Ribeiro A; Santos HA
    J Control Release; 2016 Jun; 232():29-41. PubMed ID: 27074369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation.
    Wang J; Li L; Wu L; Sun B; Du Y; Sun J; Wang Y; Fu Q; Zhang P; He Z
    Eur J Pharm Sci; 2017 Mar; 99():185-192. PubMed ID: 27989702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.
    Graves RA; Ledet GA; Glotser EY; Mitchner DM; Bostanian LA; Mandal TK
    Eur J Pharm Sci; 2015 Aug; 76():1-9. PubMed ID: 25933716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cp1-11 peptide/insulin complex loaded pH-responsive nanoparticles with enhanced oral bioactivity.
    Chen X; Ren Y; Feng Y; Xu X; Tan H; Li J
    Int J Pharm; 2019 May; 562():23-30. PubMed ID: 30877031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ
    Amin FU; Shah SA; Badshah H; Khan M; Kim MO
    J Nanobiotechnology; 2017 Feb; 15(1):12. PubMed ID: 28173812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization.
    Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S
    Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori.
    Luo M; Jia YY; Jing ZW; Li C; Zhou SY; Mei QB; Zhang BL
    Colloids Surf B Biointerfaces; 2018 Apr; 164():11-19. PubMed ID: 29367052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PLGA nanoparticles for intravitreal peptide delivery: statistical optimization, characterization and toxicity evaluation.
    Bisht R; Rupenthal ID
    Pharm Dev Technol; 2018 Apr; 23(4):324-333. PubMed ID: 27670289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles.
    Samstein RM; Perica K; Balderrama F; Look M; Fahmy TM
    Biomaterials; 2008 Feb; 29(6):703-8. PubMed ID: 18006053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization.
    Santander-Ortega MJ; Bastos-González D; Ortega-Vinuesa JL; Alonso MJ
    J Biomed Nanotechnol; 2009 Feb; 5(1):45-53. PubMed ID: 20055105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium.
    Araújo F; Shrestha N; Shahbazi MA; Fonte P; Mäkilä EM; Salonen JJ; Hirvonen JT; Granja PL; Santos HA; Sarmento B
    Biomaterials; 2014 Nov; 35(33):9199-207. PubMed ID: 25109441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The binary complex of poly(PEGMA-co-MAA) hydrogel and PLGA nanoparticles as a novel oral drug delivery system for ibuprofen delivery.
    Shang Q; Huang S; Zhang A; Feng J; Yang S
    J Biomater Sci Polym Ed; 2017 Nov; 28(16):1874-1887. PubMed ID: 28693380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zein-casein-lysine multicomposite nanoparticles are effective in modulate the intestinal permeability of ferulic acid.
    Heep G; Almeida A; Marcano R; Vieira D; Mainardes RM; Khalil NM; Sarmento B
    Int J Biol Macromol; 2019 Oct; 138():244-251. PubMed ID: 31279877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.